|
When we founded Aesica, we set out to bring something new to pharmaceutical manufacturing - an innovative, flexible and service-driven supplier of APIs, formulated products and custom synthesis solutions. Since then we've more than trebled in size and built a customer base that includes the world's largest pharmaceutical companies, leading generics manufacturers and emerging pharma companies. We believe this growth reflects the trust our customers place in us - we deliver high quality products on time, every time.
We also innovate in our technologies and in our commercial relationships, finding new ways of working to produce the APIs and products our customers need to make their businesses a success. We call this dynamic chemistry, working together with our customers to achieve outstanding results. With three major manufacturing sites, primary and secondary manufacturing capabilities and the expertise to take products from the preclinical stage right through to the market place, we believe Aesica is well-placed to deliver our vision - to be the number one supplier of APIs and formulated products to the pharmaceutical industry.
Dr Robert Hardy
Chief Executive Officer
|
